Elevance Health
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $45,145,000 | $43,646,000 | $42,577,000 | $42,647,000 |
Gross Profit | 12,196,000 | 13,074,000 | 12,031,000 | 11,313,000 |
EBITDA | 2,002,000 | 3,601,000 | 3,535,000 | 1,684,000 |
EBIT | 1,673,000 | 3,266,000 | 3,204,000 | 1,260,000 |
Net Income | 1,016,000 | 2,300,000 | 2,246,000 | 856,000 |
Net Change In Cash | 45,145,000 | 43,646,000 | 42,577,000 | 42,647,000 |
Free Cash Flow | 2,345,000 | 124,000 | 1,699,000 | -3,297,000 |
Cash | 7,866,000 | 6,497,000 | 6,226,000 | 6,526,000 |
Basic Shares | 233,100 | 233,400 | 234,200 | 235,800 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $171,340,000 | $156,595,000 | $138,639,000 | $121,867,000 |
Gross Profit | 154,047,000 | 39,953,000 | 35,994,000 | 33,822,000 |
EBITDA | 10,490,000 | 10,126,000 | 6,004,000 | 8,176,000 |
EBIT | 8,745,000 | 8,451,000 | 4,702,000 | 7,022,000 |
Net Income | 5,987,000 | 5,894,000 | 6,104,000 | 4,572,000 |
Net Change In Cash | 171,340,000 | 156,595,000 | 138,639,000 | 121,867,000 |
Cost of Revenue | 2,521,000 | -861,000 | 804,000 | |
Free Cash Flow | 6,765,000 | 7,247,000 | 7,277,000 | 9,667,000 |
Cash | 6,526,000 | 7,387,000 | 4,880,000 | 5,741,000 |
Basic Shares | 237,400 | 242,800 | 246,800 | 254,300 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $8.37 |
2024-06-30 | $10.12 |
2024-03-31 | $10.64 |
2023-12-31 | $5.62 |
